25
Participants
Start Date
July 28, 2021
Primary Completion Date
December 1, 2025
Study Completion Date
March 30, 2026
Belatacept
Patients will have tapering of their multi-drug immunosuppression, until Belatacept is the sole medication in their immunosuppression regimen. Belatacept will be administered as an infusion, as is routinely done clinically.
RECRUITING
UT Southwestern Medical Center, Dallas
Collaborators (1)
CareDx
INDUSTRY
University of Texas Southwestern Medical Center
OTHER